This inventor holds 1 USPTO granted patent. Top assignee: Zentaris Ag. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Juergen Schmidt: Innovator in Xanthone Compounds
Introduction
Juergen Schmidt is a notable inventor based in Uhldingen-Muehlhofen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his work on xanthone compounds. His innovative approach has led to advancements in the development of anticancer agents.
Latest Patents
Juergen Schmidt holds a patent for "Xanthone compounds, their preparation and use as medicament." This invention focuses on novel xanthone compounds, specifically the isolation of the natural product sootepenseone from the Annonaceae family. The patent details the identification and derivatization of sootepenseone, highlighting its potential use as an anticancer agent.
Career Highlights
Throughout his career, Schmidt has been associated with Zentaris AG, a company dedicated to developing innovative therapeutics. His work has been instrumental in advancing the understanding of xanthone compounds and their applications in medicine.
Collaborations
Juergen Schmidt has collaborated with notable colleagues, including Vichai Reutrakul and Thaiwatchai Santisuk. These partnerships have contributed to the successful development of his research and innovations.
Conclusion
Juergen Schmidt's contributions to the field of medicinal chemistry, particularly through his patent on xanthone compounds, demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future innovations in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile